{
  "id": 4964843,
  "title": "Indie semiconductor COO Wittmann sells $63,400 in stock",
  "url": "https://urgent.news/2026/09/01/indie-semiconductor-coo-wittmann-sells-63-400-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T23:21:39.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/indie-semiconductor-coo-wittmann-sells-63400-in-stock-93CH-4884728"
  },
  "original_language": "en",
  "account": "On August 31, 2026, Chief Operating Officer Michael Wittmann of indie Semiconductor, Inc. (NASDAQ:INDI) sold 17,045 shares of Class A Common Stock for $63,400. The shares were traded on the open market to pay withholding taxes on the vesting of Restricted Stock Units (RSUs). At the time of the sale, INDI shares were trading at $3.55, exhibiting high volatility with a beta of 2.77 and a 41% drop from its 52-week high of $6.05. In August 2026, Wittmann also purchased 32,958 shares at $0, received from fully vested RSUs under the company’s 2026 Short Term Incentive Bonus Plan. Additionally, he acquired 6,250 shares on the same day, also from RSUs. As of August 31, 2026, Wittmann directly owns 112,797 shares of indie Semiconductor Class A Common Stock.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Xeris Biopharma’s Beth Hecht sells $141,434 in company stock",
        "url": "https://urgent.news/2026/09/01/xeris-biopharmas-beth-hecht-sells-141-434-in-company-stock",
        "published": "2026-09-01T23:30:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}